These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23884639)

  • 1. Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.
    Mazzoleni S; Jachetti E; Morosini S; Grioni M; Piras IS; Pala M; Bulfone A; Freschi M; Bellone M; Galli R
    Stem Cells Transl Med; 2013 Sep; 2(9):678-89. PubMed ID: 23884639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.
    Atala A
    J Urol; 2014 Apr; 191(4):1181. PubMed ID: 24703155
    [No Abstract]   [Full Text] [Related]  

  • 3. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
    Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
    Front Immunol; 2020; 11():1820. PubMed ID: 33013832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model.
    Pu YS; Luo W; Lu HH; Greenberg NM; Lin SH; Gingrich JR
    J Urol; 1999 Sep; 162(3 Pt 1):892-6. PubMed ID: 10458403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation.
    Morales PR; Dillehay DL; Moody SJ; Pallas DC; Pruett S; Allgood JC; Symolon H; Merrill AH
    Drug Chem Toxicol; 2007; 30(3):197-216. PubMed ID: 17613006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression.
    Soares CR; Shibata MA; Green JE; Jorcyk CL
    Neoplasia; 2002; 4(2):112-20. PubMed ID: 11896566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM
    Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma.
    Adisetiyo H; Liang M; Liao CP; Aycock-Williams A; Cohen MB; Xu S; Neamati N; Conway EM; Cheng CY; Nikitin AY; Roy-Burman P
    PLoS One; 2013; 8(7):e69484. PubMed ID: 23936028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.
    Chiaverotti T; Couto SS; Donjacour A; Mao JH; Nagase H; Cardiff RD; Cunha GR; Balmain A
    Am J Pathol; 2008 Jan; 172(1):236-46. PubMed ID: 18156212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.
    Kang BH; Tavecchio M; Goel HL; Hsieh CC; Garlick DS; Raskett CM; Lian JB; Stein GS; Languino LR; Altieri DC
    Br J Cancer; 2011 Feb; 104(4):629-34. PubMed ID: 21285984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
    Deng Q; Tang DG
    Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
    Teichert F; Verschoyle RD; Greaves P; Edwards RE; Teahan O; Jones DJ; Wilson ID; Farmer PB; Steward WP; Gant TW; Gescher AJ; Keun HC
    Prostate; 2008 Jul; 68(10):1035-47. PubMed ID: 18459103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.
    Rybak AP; Bristow RG; Kapoor A
    Oncotarget; 2015 Feb; 6(4):1900-19. PubMed ID: 25595909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
    Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
    Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model.
    Chang HH; Chen BY; Wu CY; Tsao ZJ; Chen YY; Chang CP; Yang CR; Lin DP
    J Biomed Sci; 2011 Jan; 18(1):6. PubMed ID: 21241512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
    Jain AK; Raina K; Agarwal R
    Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.